Chemotherapy for hormone-refractory prostate cancer: beauty is in the eye of the beholder.
Beer
T
T
Division of Hematology and Oncology, Oregon Health Sciences University, Portland, Oregon, USA.
Raghavan
D
D
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003603:Cytotoxins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017063:Outcome Assessment, Health Care; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D003603:Cytotoxins